These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 2295043

  • 1. Neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin for locally advanced transitional cell carcinoma of the bladder.
    Miller RJ, Bahnson RR, Banner B, Ernstoff MS, O'Donnell WF.
    Cancer; 1990 Jan 15; 65(2):207-10. PubMed ID: 2295043
    [Abstract] [Full Text] [Related]

  • 2. Long-term follow-up in patients treated with methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) for transitional cell carcinoma of urinary bladder: cause for concern.
    Connor JP, Olsson CA, Benson MC, Rapoport F, Sawczuk IS.
    Urology; 1989 Dec 15; 34(6):353-6. PubMed ID: 2595880
    [Abstract] [Full Text] [Related]

  • 3. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse.
    Sternberg CN, Yagoda A, Scher HI, Watson RC, Geller N, Herr HW, Morse MJ, Sogani PC, Vaughan ED, Bander N.
    Cancer; 1989 Dec 15; 64(12):2448-58. PubMed ID: 2819654
    [Abstract] [Full Text] [Related]

  • 4. M-VAC chemotherapy in the management of locally advanced bladder cancer.
    Skinner DG.
    J Urol; 1988 Mar 15; 139(3):570. PubMed ID: 3343745
    [No Abstract] [Full Text] [Related]

  • 5. Primary transitional cell carcinoma of prostate: case with lymph node metastasis eradicated by neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) therapy.
    Takashi M, Sakata T, Nagai T, Kato T, Sahashi M, Koshikawa T, Miyake K.
    Urology; 1990 Jul 15; 36(1):96-8. PubMed ID: 2368239
    [Abstract] [Full Text] [Related]

  • 6. Neoadjuvant chemotherapy for locally advanced transitional cell carcinoma of the bladder: do local findings suggest a potential for salvage of the bladder?
    Zincke H, Sen SE, Hahn RG, Keating JP.
    Mayo Clin Proc; 1988 Jan 15; 63(1):16-22. PubMed ID: 3336237
    [Abstract] [Full Text] [Related]

  • 7. Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: a retrospective analysis from the University of Southern California.
    Fairey AS, Daneshmand S, Quinn D, Dorff T, Dorin R, Lieskovsky G, Schuckman A, Cai J, Miranda G, Skinner EC.
    Urol Oncol; 2013 Nov 15; 31(8):1737-43. PubMed ID: 23141776
    [Abstract] [Full Text] [Related]

  • 8. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) chemotherapy for transitional cell carcinoma: the Princess Margaret Hospital experience.
    Tannock I, Gospodarowicz M, Connolly J, Jewett M.
    J Urol; 1989 Aug 15; 142(2 Pt 1):289-92. PubMed ID: 2746745
    [Abstract] [Full Text] [Related]

  • 9. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder.
    Blick C, Hall P, Pwint T, Al-Terkait F, Crew J, Powles T, Macaulay V, Munro N, Douglas D, Kilbey N, Protheroe A, Chester JD.
    Cancer; 2012 Aug 15; 118(16):3920-7. PubMed ID: 22614698
    [Abstract] [Full Text] [Related]

  • 10. Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesion.
    Scher HI, Yagoda A, Herr HW, Sternberg CN, Bosl G, Morse MJ, Sogani PC, Watson RC, Dershaw DD, Reuter V.
    J Urol; 1988 Mar 15; 139(3):470-4. PubMed ID: 3343728
    [Abstract] [Full Text] [Related]

  • 11. Chemotherapy of advanced transitional-cell carcinoma of the bladder.
    Miller RS, Torti FM.
    Cancer Chemother Pharmacol; 1992 Mar 15; 30 Suppl():S99-110. PubMed ID: 1394829
    [Abstract] [Full Text] [Related]

  • 12. Transitional cell carcinomatous meningitis after M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) chemotherapy.
    Bishop JR, Moul JW, Maldonado L, McLeod DG.
    Urology; 1990 Oct 15; 36(4):373-7. PubMed ID: 2219624
    [Abstract] [Full Text] [Related]

  • 13. Neo-adjuvant chemotherapy and bladder preservation in locally advanced transitional cell carcinoma of the bladder.
    Sternberg CN, Pansadoro V, Calabro F, Marini L, van Rijn A, Carli PD, Giannarelli D, Platania A, Rossetti A.
    Ann Oncol; 1999 Nov 15; 10(11):1301-5. PubMed ID: 10631456
    [Abstract] [Full Text] [Related]

  • 14. Methotrexate, vinblastine, adriamycin and cisplatin (MVAC) chemotherapy for the treatment of advanced bladder carcinoma.
    Balbay MD, Ozen H, Uluçay S, Sahin A, Ergen A, Koçal C, Remzi D.
    Int Urol Nephrol; 1993 Nov 15; 25(4):351-7. PubMed ID: 8276565
    [Abstract] [Full Text] [Related]

  • 15. Perioperative methotrexate, vinblastine, doxorubicin and cisplatin (M-VAC) for poor risk transitional cell carcinoma of the bladder: an Eastern Cooperative Oncology Group pilot study.
    Dreicer R, Messing EM, Loehrer PJ, Trump DL.
    J Urol; 1990 Nov 15; 144(5):1123-6; discussion 1126-7. PubMed ID: 2231884
    [Abstract] [Full Text] [Related]

  • 16. Neoadjuvant M-VAC chemotherapy and partial cystectomy for treatment of locally invasive transitional cell carcinoma of the bladder.
    Simon SD, Srougi M.
    Prog Clin Biol Res; 1990 Nov 15; 353():169-74. PubMed ID: 2217415
    [No Abstract] [Full Text] [Related]

  • 17. Extended experience of neo-adjuvant M-VAC chemotherapy for T1-4 N0 M0 transitional cell carcinoma of the urinary bladder.
    Keating JP, Zincke H, Hahn RG, Morgan WR.
    Prog Clin Biol Res; 1990 Nov 15; 353():119-27. PubMed ID: 2217409
    [No Abstract] [Full Text] [Related]

  • 18. Histopathologic changes of transitional cell carcinoma of bladder after M-VAC chemotherapy.
    Javadpour N, Daloni P.
    Urology; 1989 Dec 15; 34(6):357-9. PubMed ID: 2595881
    [Abstract] [Full Text] [Related]

  • 19. [Neoadjuvant chemotherapy (M-VAC) in invasive cancer of the bladder. Our experience].
    González Enguita C, Caro Cebrián C, Roncalés Badal A, Gil Sanz MJ, Martínez Bengoechea J, Rioja Sanz LA.
    Arch Esp Urol; 1990 Dec 15; 43 Suppl 2():197-204. PubMed ID: 2096779
    [Abstract] [Full Text] [Related]

  • 20. Clinical and pathological evaluations of methotrexate, vinblastine, adriamycin and cisplatin chemotherapy for advanced urothelial cancers.
    Ogawa T, Gotoh A, Takenaka A, Hara I, Gohji K, Arakawa S, Matsumoto O, Kamidono S.
    Cancer Chemother Pharmacol; 1992 Dec 15; 30 Suppl():S66-71. PubMed ID: 1394822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.